Gossamer Bio, Inc. (GOSS)
9.31
-0.57
(-5.77%)
USD |
NASDAQ |
Oct 09, 16:00
9.29
-0.02
(-0.21%)
After-Hours: 20:00
Gossamer Bio Free Cash Flow : -164.59M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -164.59M |
| March 31, 2026 | -170.32M |
| December 31, 2025 | -171.34M |
| September 30, 2025 | -158.51M |
| June 30, 2025 | -154.38M |
| March 31, 2025 | 9.084M |
| December 31, 2024 | -3.468M |
| September 30, 2024 | -1.411M |
| June 30, 2024 | -3.872M |
| March 31, 2024 | -158.47M |
| December 31, 2023 | -159.16M |
| September 30, 2023 | -173.57M |
| June 30, 2023 | -176.10M |
| March 31, 2023 | -186.79M |
| Date | Value |
|---|---|
| December 31, 2022 | -187.44M |
| September 30, 2022 | -180.20M |
| June 30, 2022 | -185.73M |
| March 31, 2022 | -184.38M |
| December 31, 2021 | -190.44M |
| September 30, 2021 | -186.83M |
| June 30, 2021 | -189.50M |
| March 31, 2021 | -184.75M |
| December 31, 2020 | -177.86M |
| September 30, 2020 | -185.54M |
| June 30, 2020 | -177.14M |
| March 31, 2020 | -172.49M |
| December 31, 2019 | -147.80M |
| September 30, 2019 | -128.48M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| United Therapeutics Corp. | 1.084B |
| Arbutus Biopharma Corp. | -24.13M |
| Kura Oncology, Inc. | -117.43M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
| Alnylam Pharmaceuticals, Inc. | 793.94M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -41.39M |
| Cash from Investing (Quarterly) | 42.70M |
| Cash from Financing (Quarterly) | -1.181M |
| Free Cash Flow Per Share (Quarterly) | -10.07 |
| Free Cash Flow to Equity (Quarterly) | 121.48M |
| Free Cash Flow to Firm (Quarterly) | -38.68M |
| Free Cash Flow Yield | -556.0% |